Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

Clinical trial NCT01464099 · COMPLETED

Trial details

NCT number: NCT01464099
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 1

Start date: 2008-06-01
Primary completion: 2008-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.